OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics: Achievements and New Challenges
Casey Burton, Yinfa Ma
Current Medicinal Chemistry (2018) Vol. 26, Iss. 1, pp. 5-28
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Translational Metabolomics: Current Challenges and Future Opportunities
Farhana R. Pinu, Seyed Ali Goldansaz, Jacob Jaine
Metabolites (2019) Vol. 9, Iss. 6, pp. 108-108
Open Access | Times Cited: 170

Breast cancer detection by analyzing the volatile organic compound (VOC) signature in human urine
Judit Giró Benet, Minjun Seo, Michelle Khine, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 39

SWATH-MS for metabolomics and lipidomics: critical aspects of qualitative and quantitative analysis
Michel Raetz, R. F. Bonner, Gérard Hopfgartner
Metabolomics (2020) Vol. 16, Iss. 6
Closed Access | Times Cited: 50

LC–MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats
Hongyu Ji, Yu Liu, Fang He, et al.
Journal of Pharmaceutical and Biomedical Analysis (2018) Vol. 156, pp. 104-115
Closed Access | Times Cited: 57

Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
Xiangming Cheng, Xiaoyan Liu, Xiang Liu, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 54

Analysis of urinary VOCs using mass spectrometric methods to diagnose cancer: A review
Bruno Ruiz Brandão da Costa, Bruno Spinosa De Martinis
Clinical mass spectrometry (2020) Vol. 18, pp. 27-37
Open Access | Times Cited: 50

UHMK 1 promotes gastric cancer progression through reprogramming nucleotide metabolism
Xing Feng, Dong Ma, Jiabao Zhao, et al.
The EMBO Journal (2020) Vol. 39, Iss. 5
Open Access | Times Cited: 41

Untargeted metabolomics of prostate cancer zwitterionic and positively charged compounds in urine
Andrea Cerrato, Carmen Bedia, Anna Laura Capriotti, et al.
Analytica Chimica Acta (2021) Vol. 1158, pp. 338381-338381
Open Access | Times Cited: 34

Landscape of Innovative Methods for Early Diagnosis of Gastric Cancer: A Systematic Review
Alexandra Orășeanu, Mihaela Cristina Brisc, Octavian Maghiar, et al.
Diagnostics (2023) Vol. 13, Iss. 24, pp. 3608-3608
Open Access | Times Cited: 14

Metabolomics profile in gastrointestinal cancers: Update and future perspectives
Giulia Nannini, Gaia Meoni, Amedeo Amedei, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 20, pp. 2514-2532
Open Access | Times Cited: 37

Raman chemometric urinalysis (Rametrix) as a screen for bladder cancer
Herbert M. Huttanus, Tommy Vu, Georgi Guruli, et al.
PLoS ONE (2020) Vol. 15, Iss. 8, pp. e0237070-e0237070
Open Access | Times Cited: 35

Warburg Effect Revisited: Embodiment of Classical Biochemistry and Organic Chemistry. Current State and Prospects
Leonid G. Menchikov, Alexander A. Shestov, Anatoliy V. Popov
Biochemistry (Moscow) (2023) Vol. 88, Iss. S1, pp. S1-S20
Closed Access | Times Cited: 11

An untargeted metabolomics approach to evaluate enzymatically deconjugated steroids and intact steroid conjugates in urine as diagnostic biomarkers for adrenal tumors
Nora Vogg, E. Jeffrey North, Arne Gessner, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2025)
Closed Access

Understanding the role of biomarkers in cancer
Sumira Malik, Swati Priya, Sagar Mondal, et al.
Elsevier eBooks (2025), pp. 43-61
Closed Access

Evaluation of heavy metals and metabolites in the urine of patients with breast cancer
Yuhao Men, Ling Li, Fen Zhang, et al.
Oncology Letters (2019)
Open Access | Times Cited: 32

Urine‐based liquid biopsy in bladder cancer: Opportunities and challenges
Gang Wang, Wan Jin, Zilin Xu, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 10

UPLC-Q-TOF-MS-based unbiased serum metabolomics investigation of cholangiocarcinoma
Xiaowei Wang, Xuefeng Xu, Ran Jia, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access

Identification of metabolites in plasma for predicting survival in glioblastoma
Jie Shen, Renduo Song, Tiffany R. Hodges, et al.
Molecular Carcinogenesis (2018) Vol. 57, Iss. 8, pp. 1078-1084
Closed Access | Times Cited: 28

Development of a prognostic pyroptosis-related gene signature for head and neck squamous cell carcinoma patient
Weiwen Zhu, Jiayi Zhang, Mengyao Wang, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 14

Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments
Jie Qiu, Da Qian, Yuancong Jiang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8

Metabolomics Analysis and Diagnosis of Lung Cancer: Insights from Diverse Sample Types
Simin Liang, Xiujun Cao, Yingshuang Wang, et al.
International Journal of Medical Sciences (2023) Vol. 21, Iss. 2, pp. 234-252
Open Access | Times Cited: 8

Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal
Dawei Yang, Xiaofang Yang, Yang Li, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 22

Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches
Nuria Gómez-Cebrián, José Luís Poveda, Antonio Pineda‐Lucena, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 596-596
Open Access | Times Cited: 14

Page 1 - Next Page

Scroll to top